Sponsor content
190 result(s) found, displaying 41 to 50
-
Prescription medicine registrationActive ingredients: concizumab.
-
Prescription medicine registrationActive ingredients: Semaglutide.
-
Australian public assessment report (AusPar)Wegovy (semaglutide) was approved for weight management in obese adolescents ages 12 years and above (as an adjunct to a reduced-calorie diet and increased physical activity).
-
Australian public assessment report (AusPar)Wegovy (semaglutide) was approved as an adjunct to a reduced-energy diet and increased physical activity for chronic weight management (including weight loss and weight maintenance) in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOGROYA somapacitan 15 mg (10 mg/mL) solution for injection prefilled pen.
-
Prescription medicine registrationActive ingredients: nonacog beta pegol.
-
Prescription medicine decision summaryAwiqli (insulin icodec) has been approved for the treatment of type 1 and type 2 diabetes in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 15 mg / 1.5 mL solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 150mg / 1.5 mL solution for injection prefilled pen.